Core Laboratories Inc. (CLB)
Core Laboratories Inc. brought in $516.7M of revenue over the twelve months to September 30, 2026, down 0.1% from a year earlier. Net income was $15.6M, a net margin of 3.0%. Operating cash flow minus capital spending left $25.8M of free cash flow in fiscal 2025. At September 30, 2026 it held $21.4M in cash against $114.8M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on October 30, 2026.
Key facts about Core Laboratories Inc.
- Net worth
- Core Laboratories Inc. has a market value (market cap) of $414.3M at the latest share price, and shareholders' equity of $278M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $526.5M (+0.5% year on year), with net income of $29.7M. Over the 12 months to September 30, 2026: revenue $516.7M, net income $15.6M.
- Cash flow
- In fiscal 2025 operations brought in $37M of cash; after $11.2M of capital spending, free cash flow was $25.8M.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on October 30, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Core Laboratories Inc.'s next report is expected around February 3, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
- Dividend
- Core Laboratories Inc. paid dividends of $0.04 per share in fiscal 2025, a yield of 0.44% at the current price.
What Core Laboratories Inc. does
Core Laboratories Inc. is registered with the SEC under industry code SIC 1389 (Oil & Gas Field Services, NEC). Its shares trade on NYSE under the ticker CLB.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $526.5M | $29.7M | $0.63 | $25.8M |
| 2024 | $523.8M | $31.4M | $0.66 | $44.5M |
| 2023 | $509.8M | $36.7M | $0.77 | $14.2M |
| 2023 | $489.7M | $19.5M | $0.42 | $14.7M |
| 2021 | $470.3M | $19.7M | $0.42 | $23M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where CLB ranks in Energy
Dividends
Core Laboratories Inc. paid $0.04 per share in fiscal 2025. At the current price that is a yield of 0.44%. It paid out $1.9M in cash dividends, 6% of its net income.
| Fiscal year | Per share | Paid out | Of profit |
|---|---|---|---|
| 2025 | $0.04 | $1.9M | 6% |
| 2024 | $0.04 | $1.9M | 6% |
| 2023 | $0.04 | $1.9M | 5% |
| 2023 | $0.04 | $1.9M | 10% |
| 2021 | $0.04 | $1.8M | 9% |
Latest SEC filings
What Core Laboratories Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- October 30, 2026Quarterly report 10-Q · period to September 30, 2026Revenue fell 1.8% to $132.1M versus the same quarter last year; diluted EPS $0.12 versus $0.30.
- October 28, 2026
- August 25, 2026
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 6, 2026Passive stake changed SCHEDULE 13G/A
- July 30, 2026Quarterly report 10-Q · period to June 30, 2026Revenue fell 4.3% to $124.6M versus the same quarter last year; diluted EPS $0.13 versus $0.22.
- July 29, 2026
- June 29, 2026
- May 15, 2026Passive stake changed SCHEDULE 13G/A
What is CLB worth? A DCF from its reported cash flow
Insider trades
What the people running Core Laboratories Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 4 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| October 1, 2026 | Teo Sow HangCAO & Treasurer | Shares withheld for tax | 99 | $966.2 |
| October 1, 2026 | Teo Sow HangCAO & Treasurer | Exercised options | 250 | - |
| October 1, 2026 | Tattoli Mark DamianSVP, Gen Counsel & Secretary | Shares withheld for tax | 276 | $2.7K |
| October 1, 2026 | Tattoli Mark DamianSVP, Gen Counsel & Secretary | Exercised options | 700 | - |
| August 1, 2026 | Tattoli Mark DamianSVP, Gen Counsel & Secretary | Shares withheld for tax | 99 | $1.1K |
| August 1, 2026 | Tattoli Mark DamianSVP, Gen Counsel & Secretary | Exercised options | 250 | - |
| August 1, 2026 | Teo Sow HangCAO & Treasurer | Shares withheld for tax | 108 | $1.1K |
| August 1, 2026 | Teo Sow HangCAO & Treasurer | Exercised options | 240 | - |
Who owns CLB
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Ariel Investments, LLC13G, passive | 30.5% | August 14, 2026 |
| Earnest Partners LLC13G, passive | 6.9% | February 12, 2026 |
| Disciplined Growth Investors Inc13G, passive | 6.6% | August 14, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 186 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Ariel Investments, LLC | 14,074,945 | +904,557 |
| BlackRock, Inc. | 7,460,118 | +251,615 |
| Disciplined Growth Investors Inc | 3,042,177 | -1,894,938 |
| Earnest Partners LLC | 2,941,004 | -114,992 |
| State Street Corp | 2,176,480 | +115,943 |
| CWA Asset Management Group, LLC | 1,755,085 | +14,084 |
| Vanguard Capital Management LLC | 1,590,521 | -29,342 |
| Dimensional Fund Advisors LP | 1,548,203 | +195,874 |
| Schroder Investment Management Group | 1,543,638 | new |
| Vanguard Portfolio Management LLC | 1,275,421 | +20,585 |
| Geode Capital Management, LLC | 1,193,824 | +55,866 |
| Gendell Jeffrey L | 1,090,973 | +442,513 |
| Heartland Advisors Inc | 1,058,311 | +908,311 |
| Goldman Sachs Group Inc | 751,643 | -97,258 |
| Evergreen Capital Management LLC | 669,508 | new |
| Morgan Stanley | 656,146 | +209,364 |
| Northern Trust Corp | 608,202 | +42,916 |
| Charles Schwab Investment Management Inc | 565,065 | -121,885 |
| UBS Group AG | 461,777 | +30,124 |
| Fisher Asset Management, LLC | 447,949 | -288,798 |
Insiders
11 insiders reported holding 693,790 shares in total, about $6.3M at the last price.
| Holder | Shares |
|---|---|
| Bruno LawrenceChairman and CEO, Director | 262,438 |
| Hill Christopher ScottSVP & CFO | 142,354 |
| Carnes Martha Z.Director | 54,397 |
| Gresham GwendolynSVP | 52,527 |
| Klingensmith Harvey RobertDirector | 50,031 |
| Temeng KwakuDirector | 33,597 |
| Murray KatherineDirector | 29,290 |
| Tattoli Mark DamianSVP, Gen Counsel & Secretary | 28,365 |
| Anastasio CurtDirector | 23,805 |
| Teo Sow HangCAO & Treasurer | 8,917 |
Questions about CLB
What does Core Laboratories Inc. do?
Core Laboratories Inc. is a company in the Energy sector, listed on NYSE as CLB. Its shares trade on NYSE under the ticker CLB.
What is Core Laboratories Inc.'s net worth?
Core Laboratories Inc. has a market value (market cap) of $414.3M at the latest share price, and shareholders' equity of $278M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Core Laboratories Inc. profitable?
Yes. Over the twelve months to September 30, 2026 it reported net income of $15.6M on revenue of $516.7M, a net margin of 3.0%.
How much revenue does Core Laboratories Inc. make?
Over the twelve months to September 30, 2026 Core Laboratories Inc. reported revenue of $516.7M. That is 0.1% less than a year earlier.
When did Core Laboratories Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on October 30, 2026. It covers the period to September 30, 2026.
When is Core Laboratories Inc.'s next earnings report?
Core Laboratories Inc.'s next report is expected around February 3, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Does Core Laboratories Inc. pay a dividend?
Yes. Core Laboratories Inc. paid dividends of $0.04 per share in fiscal 2025, a yield of 0.44% at the current price.
Similar companies
Compare CLB with
Follow CLB
Get an email when Core Laboratories Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Core Laboratories Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.